These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 27115677)

  • 1. Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease.
    Ajith TA; Jayakumar TG
    Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):649-58. PubMed ID: 27115677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PPAR in cardiovascular diseases.
    Das SK; Chakrabarti R
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):193-209. PubMed ID: 18221086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsiao FC; Chen YJ
    Diabetes Res Clin Pract; 2013 Jun; 100(3):330-9. PubMed ID: 23369225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of PPARs on regulating myocardial energy and lipid homeostasis.
    Yang Q; Li Y
    J Mol Med (Berl); 2007 Jul; 85(7):697-706. PubMed ID: 17356846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats.
    Lee TI; Kao YH; Chen YC; Tsai WC; Chung CC; Chen YJ
    Int J Cardiol; 2014 Sep; 176(1):151-7. PubMed ID: 25062566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
    Mirza AZ; Althagafi II; Shamshad H
    Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
    Khuchua Z; Glukhov AI; Strauss AW; Javadov S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPAR regulatory system in cardiac physiology and disease.
    Finck BN
    Cardiovasc Res; 2007 Jan; 73(2):269-77. PubMed ID: 17010956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice.
    Derosa G; Sahebkar A; Maffioli P
    J Cell Physiol; 2018 Jan; 233(1):153-161. PubMed ID: 28098353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARs and Myocardial Infarction.
    Wagner KD; Wagner N
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.
    Barlaka E; Galatou E; Mellidis K; Ravingerova T; Lazou A
    Cardiovasc Ther; 2016 Feb; 34(1):37-48. PubMed ID: 26589375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors as attractive antiobesity targets.
    Zhang F; Lavan B; Gregoire FM
    Drug News Perspect; 2004 Dec; 17(10):661-9. PubMed ID: 15696231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart.
    Finck BN
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):391-6. PubMed ID: 15192440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.